Valeant Pharma (VRX) Was Top Stock for TD Ameritrade Retail Clients on Friday - Sherrod
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailValeant Pharma (NYSE: VRX) was the most heavily traded stock for TD Ameritrade retail investors on Friday, Nicole Sherrod said. Buys heavily outweighed sells.
$VRX was the #1 top traded stock for TD Ameritrade retail investors on Friday. Buys heavily outweighing sells.
— Nicole Sherrod (@TDANSherrod) November 2, 2015
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump Called Musk and Asked Him to Lift Ukraine Starlink Restrictions -- WSJ
- Meta Plans To Introduce New Non-voting Stock - Semafor
- U.S. signs Lockheed Martin deal for minimum of 850 F-35 jets
Create E-mail Alert Related Categories
Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
